Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Effect of Camel Milk on Chronic Hepatitis C

NCT02216045

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Faculty of Traditional Medicine Mashhad, Razavi Khorasan Province, Iran
  • Mashhad University of Medical Sciences Mashhad, Razavi Khorasan Province, Iran
View Trial Details
Completed

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

NCT01559844

Conditions
Adenocarcinoma, Blood-Borne Infections, Bronchial Diseases, +29 more
Locations
  • UCLA Medical Center-The Pfleger Liver Institute Los Angeles, California, United States
  • UC San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 15 locations
View Trial Details
Completed

A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

NCT01447420

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Vitória, Espírito Santo, Brazil
  • Salvador, Estado de Bahia, Brazil
  • Juiz de Fora, Minas Gerais, Brazil
  • Rio de Janeiro, Brazil
View all 15 locations
View Trial Details
Completed

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

NCT00087607

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Little Rock, Arkansas, United States
  • Sacramento, California, United States
  • San Diego, California, United States
View all 41 locations
View Trial Details
Completed

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

NCT01330316

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • 1220.48.0004 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1220.48.0091 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
  • 1220.48.0011 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1220.48.0018 Boehringer Ingelheim Investigational Site Oceanside, California, United States
View all 87 locations
View Trial Details

Related conditions